acitretin has been researched along with Pityriasis Rubra Pilaris in 38 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (7.89) | 18.2507 |
2000's | 13 (34.21) | 29.6817 |
2010's | 14 (36.84) | 24.3611 |
2020's | 8 (21.05) | 2.80 |
Authors | Studies |
---|---|
Baker, CS; Daniel, BS; Foley, P; Ringin, S | 1 |
Katharina, M; Martin, L; Matthias, B; Sylvia, S; Ulrich, M | 1 |
Gamonal, ACC; Gamonal, SBL; Marques, NCV; Pereira, HMB | 1 |
Su-Chun, H; Xiao-Yan, W; Ying, Y; Yu-Hua, L | 1 |
Crespo-Erchiga, A; Gomez-Moyano, E | 1 |
Akin, R; Cook, E; Kollipara, S; Tarbox, M; Tran, KW | 1 |
Camela, E; De Fata Salvatores, G; Di Caterino, P; Fabbrocini, G; Lo Presti, M; Megna, M; Miano, C | 1 |
Kromer, C; Lippert, U; Mössner, R; Schön, MP | 1 |
Chia, SY; Koh, MJA; Rafi'ee, K; Tan, EC; Wei, H; Wong, GHZ | 1 |
Atzori, L; Ferreli, C; Lappi, A; Pilloni, L; Pinna, AL; Rongioletti, F; Zanniello, R | 1 |
Chastagner, M; Hoelt, P; Jullien, D; Kanitakis, J; Villani, AP | 1 |
Duran, VD; Gajinov, ZT; Matić, MB; Prcić, ST; Vucković, N; Vujanović, LM | 1 |
Dalmau, J; Fernández-Figueras, MT; López-Ferrer, A; Puig, L | 1 |
Abbas, O; Kibbi, AG; Kurban, M; Marrouche, N | 1 |
Chung, PK; van der Kuip, M; Vergunst, CE | 1 |
Byekova, Y; Sami, N | 1 |
Carvalho, S; Mota, F; Sanches, M; Selores, M | 1 |
Kim, J; Kumarasinghe, SP; Papadimitriou, J; Yu, L | 1 |
Généreux, AD; Wetter, DA | 1 |
Chen, W; Cheng, YW; Chiu, HC; Huang, PH; Lee, JY; Lin, WL; Shih, IH; Yang, CC; Yu, YS | 1 |
Doughty, LE; Stetson, CL; Wells, MJ | 1 |
Goldberg, LJ; Koff, AB; Sebastian, A | 1 |
Antonelli, G; Di Giampetruzzi, AR; Didona, B; Garcovich, A; Garcovich, S | 1 |
Chiu, HY; Tsai, TF | 1 |
Artik, S; Megahed, M; Ruzicka, T | 1 |
White, KL | 1 |
Gilmore, RE | 1 |
Brzezińska-Wcisło, L; Krauze, E; Lis-Swiety, A; Wcisło-Dziadecka, D | 1 |
George, SJ; Hsu, S; Lu, R | 1 |
Argyriou, G; Christofidou, E; Gregoriou, S; Rigopoulos, D; Vranou, A | 1 |
Davis, KF; Meshkinpour, A; Murase, JE; Rosenberg, FR; Sorenson, EP; Wu, JJ | 1 |
van de Kerkhof, PC; van Dooren-Greebe, RJ | 1 |
Jacyk, WK | 1 |
Logan, RA; Varma, S | 1 |
Kirby, B; Watson, R | 1 |
Ehnis, A; Herbst, RA; Kapp, A; Kiehl, P; Vogelbruch, M; Weiss, J | 1 |
Bröcker, EB; Hamm, H; Hofmann, UB; Terheyden, P | 1 |
Hertel, K; Höffken, K; Kloos, C; Metzner, U; Müller, UA; Raabe, G; Schreiber, J | 1 |
2 review(s) available for acitretin and Pityriasis Rubra Pilaris
Article | Year |
---|---|
Erythrodermic pityriasis rubra pilaris treatment: Two case reports and literature review.
Topics: Acitretin; Dermatologic Agents; Humans; Pityriasis Rubra Pilaris; Ultraviolet Therapy; Ustekinumab | 2020 |
Exanthematic pityriasis rubra pilaris.
Topics: Acitretin; Facial Dermatoses; Humans; Keratolytic Agents; Male; Middle Aged; Pityriasis Rubra Pilaris; Remission, Spontaneous; Scalp Dermatoses | 1999 |
36 other study(ies) available for acitretin and Pityriasis Rubra Pilaris
Article | Year |
---|---|
Pityriasis rubra pilaris treatment options: A retrospective case series from a tertiary hospital.
Topics: Acitretin; Adult; Australia; Child; Humans; Pityriasis Rubra Pilaris; Retrospective Studies; Tertiary Care Centers | 2021 |
Successful treatment of a child's pityriasis rubra pilaris (PRP) with ustekinumab and acitretin.
Topics: Acitretin; Adult; Child; Child, Preschool; Female; Humans; Pityriasis Rubra Pilaris; Psoriasis; Ustekinumab | 2022 |
Pityriasis rubra pilaris (type I) following administration of the BNT162b2 mRNA COVID-19 vaccine: Successful treatment with ustekinumab and acitretin.
Topics: Acitretin; BNT162 Vaccine; COVID-19; COVID-19 Vaccines; Humans; Pityriasis Rubra Pilaris; RNA, Messenger; Ustekinumab | 2022 |
A case of pityriasis rubra pilaris treated with tofacitinib after failure with acitretin and ixekizumab.
Topics: Acitretin; Antibodies, Monoclonal, Humanized; Humans; Pityriasis Rubra Pilaris | 2023 |
Erythroderma secondary to pityriasis rubra pilaris.
Topics: Acitretin; Aged; Dermatitis, Exfoliative; Dermoscopy; Female; Humans; Pityriasis Rubra Pilaris; Spain | 2019 |
A case of resistant pityriasis ribra pilaris responsive to combination acitrentin and ustekinumab.
Topics: Acitretin; Aged, 80 and over; Dermatologic Agents; Drug Therapy, Combination; Humans; Keratolytic Agents; Male; Pityriasis Rubra Pilaris; Ustekinumab | 2020 |
Treatment of pityriasis rubra pilaris: a case series of 28 patients.
Topics: Acitretin; Biological Products; Cyclosporine; Dermatologic Agents; Drug Therapy, Combination; Female; Humans; Infliximab; Male; Methotrexate; Middle Aged; Pityriasis Rubra Pilaris; Retrospective Studies; Smoking; Ustekinumab | 2020 |
CARD14-associated papulosquamous eruption (CAPE) in a toddler responding to treatment with acitretin.
Topics: Acitretin; CARD Signaling Adaptor Proteins; Child, Preschool; Female; Guanylate Cyclase; Humans; Membrane Proteins; Pityriasis Rubra Pilaris | 2021 |
Successful treatment of erythrodermic pityriasis rubra pilaris with acitretin.
Topics: Acitretin; Dermatitis, Exfoliative; Humans; Keratolytic Agents; Male; Middle Aged; Pityriasis Rubra Pilaris | 2018 |
Successful treatment of TNFα inhibitor-resistant pityriasis rubra pilaris with ixekizumab and acitretin.
Topics: Acitretin; Adalimumab; Antibodies, Monoclonal, Humanized; Dermatologic Agents; Drug Resistance; Drug Therapy, Combination; Female; Humans; Keratolytic Agents; Middle Aged; Pityriasis Rubra Pilaris; Tumor Necrosis Factor-alpha | 2019 |
Drug-related pityriasis rubra pilaris with acantholysis.
Topics: Acantholysis; Acitretin; Anticholesteremic Agents; Head; Humans; Keratolytic Agents; Male; Middle Aged; Pityriasis Rubra Pilaris; Simvastatin; Thorax; Treatment Outcome | 2013 |
Pityriasis rubra pilaris triggered by photodynamic therapy with response to tumor necrosis factor α-blocking agents and acitretin.
Topics: Acitretin; Antibodies, Monoclonal; Antirheumatic Agents; Drug Therapy, Combination; Etanercept; Humans; Immunoglobulin G; Infliximab; Keratolytic Agents; Keratosis, Actinic; Male; Middle Aged; Photochemotherapy; Pityriasis Rubra Pilaris; Receptors, Tumor Necrosis Factor; Tumor Necrosis Factor-alpha | 2014 |
Pityriasis rubra pilaris: clinicopathological study of 32 cases from Lebanon.
Topics: Acitretin; Administration, Cutaneous; Adolescent; Adult; Aged; Child; Child, Preschool; Emollients; Eosinophils; Female; Humans; Isotretinoin; Keratolytic Agents; Lebanon; Male; Middle Aged; Nicotinic Acids; Pityriasis Rubra Pilaris; Retrospective Studies; Steroids; Young Adult | 2014 |
[A girl with desquamation of hands and feet].
Topics: Acitretin; Child, Preschool; Female; Humans; Keratolytic Agents; Pityriasis Rubra Pilaris; Treatment Outcome | 2014 |
Successful response of refractory type I adult-onset pityriasis rubra pilaris with ustekinumab and acitretin combination therapy.
Topics: Acitretin; Aged; Dermatologic Agents; Drug Therapy, Combination; Humans; Keratolytic Agents; Male; Pityriasis Rubra Pilaris; Ustekinumab | 2015 |
Late onset pityriasis rubra pilaris type IV treated with low-dose acitretin.
Topics: Acitretin; Humans; Keratolytic Agents; Male; Pityriasis Rubra Pilaris; Young Adult | 2016 |
Cyclical Inguinal Keratoderma: A New Clinical Entity or a Variant of Pityriasis Rubra Pilaris?
Topics: Acitretin; Biopsy, Needle; Diagnosis, Differential; Humans; Immunohistochemistry; Keratosis; Male; Middle Aged; Pityriasis Rubra Pilaris; Pruritus; Recurrence; Scrotum; Skin Diseases; Thigh; Treatment Outcome | 2016 |
Widespread erythematous skin eruption.
Topics: Acitretin; Biopsy; Diagnosis, Differential; Female; Humans; Keratolytic Agents; Middle Aged; Pityriasis Rubra Pilaris; Skin; Treatment Outcome; Vitamin A | 2017 |
Juvenile pityriasis rubra pilaris: report of 28 cases in Taiwan.
Topics: Acitretin; Adolescent; Child; Child, Preschool; Female; Humans; Infant; Male; Pityriasis Rubra Pilaris; Retrospective Studies; Taiwan | 2008 |
Pityriasis rubra pilaris with epidermolytic hyperkeratosis.
Topics: Acitretin; Erythema; Humans; Hyperkeratosis, Epidermolytic; Keratolytic Agents; Male; Middle Aged; Pityriasis Rubra Pilaris; Skin | 2008 |
PRP with subcorneal acantholysis: case report and review.
Topics: Acantholysis; Acitretin; Aged; Diagnosis, Differential; Epidermis; Female; Humans; Keratolytic Agents; Pemphigus; Pityriasis Rubra Pilaris | 2010 |
Treatment of refractory adult-onset pityriasis rubra pilaris with TNF-alpha antagonists: a case series.
Topics: Acitretin; Adult; Antibodies, Monoclonal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Etanercept; Female; Humans; Immunoglobulin G; Infliximab; Keratolytic Agents; Male; Middle Aged; Pityriasis Rubra Pilaris; Receptors, Tumor Necrosis Factor; Retrospective Studies; Severity of Illness Index; Treatment Outcome; Tumor Necrosis Factor-alpha | 2010 |
Pityriasis rubra pilaris with polyarthritis treated with adalimumab.
Topics: Acitretin; Adalimumab; Adult; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis; Female; Humans; Keratolytic Agents; Pityriasis Rubra Pilaris; Young Adult | 2013 |
[Pityriasis rubra pilaris. Case reports and review of the literature].
Topics: Acitretin; Administration, Oral; Adult; Aged; Biopsy; Chronic Disease; Diagnosis, Differential; Female; Humans; Keratolytic Agents; Pityriasis Rubra Pilaris; Prognosis; PUVA Therapy; Skin; Time Factors | 2003 |
Pityriasis rubra pilaris.
Topics: Acitretin; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Keratolytic Agents; Male; Middle Aged; Ointments; Pityriasis Rubra Pilaris; Tacrolimus | 2003 |
Living with pityriasis rubra pilaris.
Topics: Acitretin; Activities of Daily Living; Adaptation, Psychological; Aged; Attitude to Health; Biopsy; Cost of Illness; Humans; Keratolytic Agents; Male; Patient Education as Topic; Pityriasis Rubra Pilaris; Rare Diseases; Self Care; Self-Help Groups; Skin Care; Social Support | 2005 |
[Diagnostic and therapeutic difficultes in pityriasis rubra pilaris--case report].
Topics: Acitretin; Anti-Bacterial Agents; Anti-Inflammatory Agents; Calcium Carbonate; Cefuroxime; Chronic Disease; Diagnosis, Differential; Drug Therapy, Combination; Histamine H2 Antagonists; Humans; Hydroxycholecalciferols; Keratolytic Agents; Male; Methylprednisolone; Middle Aged; Pityriasis Rubra Pilaris; Ranitidine | 2005 |
Pityriasis rubra pilaris: failure of combination treatment with acitretin and infliximab.
Topics: Acitretin; Anti-Inflammatory Agents; Antibodies, Monoclonal; Dermatologic Agents; Drug Resistance; Humans; Infliximab; Keratolytic Agents; Male; Middle Aged; Pityriasis Rubra Pilaris; Tumor Necrosis Factor-alpha | 2006 |
Treatment of pityriasis rubra pilaris with pimecrolimus cream 1%.
Topics: Acitretin; Administration, Topical; Adult; Dermatologic Agents; Face; Humans; Keratolytic Agents; Male; Ointments; Pityriasis Rubra Pilaris; Scalp; Skin; Tacrolimus | 2007 |
Clinical improvement of pityriasis rubra pilaris with combination etanercept and acitretin therapy.
Topics: Acitretin; Drug Therapy, Combination; Etanercept; Humans; Immunoglobulin G; Male; Middle Aged; Pityriasis Rubra Pilaris; Receptors, Tumor Necrosis Factor; Treatment Outcome | 2007 |
Extensive extraspinal hyperostoses after long-term oral retinoid treatment in a patient with pityriasis rubra pilaris.
Topics: Acetabulum; Acitretin; Adolescent; Adult; Azathioprine; Child; Etretinate; Exostoses; Femur Neck; Follow-Up Studies; Humans; Hyperostosis; Male; Methotrexate; Pityriasis Rubra Pilaris; Retinoids; Tretinoin | 1995 |
Pityriasis rubra pilaris in black South Africans.
Topics: Acitretin; Adolescent; Adult; Age of Onset; Black People; Child; Child, Preschool; Dermatologic Agents; Disease Progression; Emollients; Female; Humans; Infant; Keratolytic Agents; Male; Methotrexate; Middle Aged; Pityriasis Rubra Pilaris; Prospective Studies; South Africa; Treatment Outcome; Treatment Refusal | 1999 |
Pityriasis rubra pilaris treated with acitretin and narrow-band ultraviolet B (Re-TL-01)
Topics: Acitretin; Child; Combined Modality Therapy; Female; Humans; Keratolytic Agents; Pityriasis Rubra Pilaris; Ultraviolet Therapy | 2000 |
Combined ultraviolet A1 radiation and acitretin therapy as a treatment option for pityriasis rubra pilaris.
Topics: Acitretin; Drug Therapy, Combination; Female; Humans; Keratolytic Agents; Middle Aged; Pityriasis Rubra Pilaris; PUVA Therapy | 2000 |
[Erythroderma after corticosteroid withdrawal in papulosquamous dermatosis in children. Diagnosis: pityriasis rubra pilaris, classic juvenile type].
Topics: Acitretin; Adult; Age Factors; Anti-Inflammatory Agents; Child, Preschool; Dermatitis, Exfoliative; Dermatologic Agents; Diagnosis, Differential; Female; Humans; Keratolytic Agents; Methotrexate; Pityriasis Rubra Pilaris; Prednisolone; PUVA Therapy; Retinoids; Substance Withdrawal Syndrome | 2001 |
[Paraneoplastic pityriasis rubra pilaris in metastatic adenocarcinoma without diagnosable primary].
Topics: Acitretin; Adenocarcinoma; Aged; Anti-Inflammatory Agents; Biopsy; Drug Therapy, Combination; Female; Humans; Immunohistochemistry; Keratolytic Agents; Neoplasms, Unknown Primary; Paraneoplastic Syndromes; Pityriasis Rubra Pilaris; Prednisolone; Skin | 2002 |